Market cap
₹635 cr
Loading the extract…
Loading the extract…
Healthcare · Pharmaceuticals
BAFNAPH · NSE BAFNAPH · BSE 532989
Market cap
₹635 cr
Price
274
52w high
279
52w low
77
PE
57.2
Industry PE
—
Book value
40.6
Dividend yield
0%
ROCE
11.9
ROE
12.3
Debt / equity
—
EPS
—
No description in this extract.
| Line | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 |
|---|---|---|---|---|---|
| Depreciation | 3 | 3 | 4 | 4 | 5 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |
| EPS in Rs | -104.54 | -7.98 | -7.08 | -10.23 | -7.52 |
| Expenses | 41 | 57 | 81 | 71 | 85 |
| Interest | 0 | 2 | 7 | 11 | 13 |
| Net Profit | -24 | -18 | -17 |
| Line | 2019-09-30 | 2019-06-30 | 2018-09-30 | 2018-06-30 |
|---|---|---|---|---|
| Depreciation | 0.72 | 1.02 | 0.75 | 1 |
| EPS in Rs | -2.49 | -0.9 | -0.54 | -1.49 |
| Expenses | 11.95 | 9.71 | 8.66 | 13.77 |
| Interest | 0.04 | 0.13 | 0.62 | 0.83 |
| Net Profit | -0.59 | -2.13 | -1.28 | -3.52 |
| OPM % | -3.28 | -41.75 | 2.04 | -15.23 |
| Line | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| DIIs | 0 | 0 | — | — | — | 0 | — | — |
| FIIs | 9.34 | 9.34 | 9.34 | 9.34 | 9.34 | 8.53 | 0 | 0 |
| Promoters | 75 | 75 | 75 | 75 | 75 | 75 | 88.29 | 88.29 |
| Public | 15.66 |
| -19 |
| -15 |
| OPM % | 2.9 | -30 | -77 | -9 | 0.6 |
| Operating Profit | 1 | -13 | -35 | -6 | 1 |
| Other Income | -22 | 1 | 31 | 1 | 2 |
| Profit before tax | -24 | -17 | -15 | -20 | -15 |
| Sales | 42 | 44 | 46 | 65 | 85 |
| Tax % | 0 | 6 | 15 | -4 | -1 |
| Operating Profit |
| -0.38 |
| -2.86 |
| 0.18 |
| -1.82 |
| Other Income | 0.59 | 0.3 | -0.03 | 0.09 |
| Profit before tax | -0.55 | -3.71 | -1.22 | -3.56 |
| Raw PDF | — | — | — | — |
| Sales | 11.57 | 6.85 | 8.84 | 11.95 |
| Tax % | 7.27 | -42.59 | 4.1 | -1.12 |
| 15.66 |
| 15.66 |
| 15.66 |
| 15.66 |
| 16.47 |
| 11.7 |
| 11.7 |